LOS ANGELES, March 15, 2017 -- City National Bank today announced that it will increase its prime lending rate from 3.75 percent to 4.00 percent, effective March 16, 2017.
About City National
With $45.1 billion in assets, City National Bank provides banking, investment and trust services through 72 offices, including 16 full-service regional centers, in Southern California, the San Francisco Bay Area, Nevada, New York City, Nashville and Atlanta. In addition, the company and its investment affiliates manage or administer $55.5 billion in client investment assets.
City National is a subsidiary of Royal Bank of Canada (RBC), one of North America’s leading diversified financial services companies. RBC serves more than 16 million personal, business, public sector and institutional clients through offices in Canada, the United States and 35 other countries.
For more information about City National, visit the company’s website at cnb.com.
Media: Cary Walker, City National Bank, 213.673.7615 [email protected]


Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 



